Trial · NCT07901725
Registered outcomes38
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 38 of 38
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Occurrence of TEAEs | Up to 7 years | Part 2 |
| Secondary | Severity of TEAEs | Up to 7 years | Part 2 |
| Secondary | Occurrence of AESI | Up to 7 years | Part 2 |
| Secondary | Severity of AESI | Up to 7 years | Part 2 |
| Secondary | Occurrence of SAEs | Up to 7 years | Part 2 |
| Secondary | Severity of SAEs | Up to 7 years | Part 2 |
| Secondary | Change from baseline in Short Form Health Survey 36 version 2 (SF-36v2) General Health (GH) scale | Up to 7 years | Part 2 |
| Secondary | Change from baseline in EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Visual Analog Scale (VAS) | Up to 7 years | Part 2 |
| Secondary | Change from baseline in SF-36v2 Physical Component Score (PCS) | Up to 7 years | Part 2 |
| Secondary | Change from baseline in SF-36v2 Physical Functioning (PF) scale | Up to 7 years | Part 2 |
| Secondary | Change from baseline in SF-36v2 Role Physical (RP) scale | Up to 7 years | Part 2 |
| Secondary | Change from baseline in FACIT (Functional Assessment of Chronic Illness Therapy)-Dyspnea Part I (Dyspnea Severity Scale) | Up to 7 years | Part 2 |
| Secondary | Change from baseline in FACIT-Fatigue scale | Up to 7 years | Part 2 |
| Secondary | Proportion of time with high side-effect bother during treatment per Functional Assessment of Chronic Illness Therapy (FACIT) Item Global Physical (GP) 5 score ≥3 | Up to 24 months | Part 2 |
| Secondary | Occurrence of high side-effect bother at on-treatment visits per FACIT Item GP5 score ≥3 | Up to 24 months | Part 2 |
| Secondary | Concentrations of linvoseltamab in serum | Up to 7 years | Part 2 |
| Secondary | Occurrence of Anti-Drug Antibodies (ADAs) to linvoseltamab | Up to 7 years | Part 2 |
| Secondary | Magnitude of Anti-Drug Antibodies (ADAs) to linvoseltamab | Up to 7 years | Part 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07901725/registered?page=2